title: Low-dose ghrelin infusion--evidence against a hormonal role in food intake.
abstract: Ghrelin is the only peripheral orexigenic peptide of gastrointestinal origin. Its preprandial increase is supposed to initiate food intake. This assumption is based on studies with intravenously infused ghrelin in rather high doses and the correlation between ghrelin levels and hunger sensations. As yet it is unclear whether or not low dose ghrelin resulting in physiological and moderately supraphysiological plasma levels has an effect on hunger sensations, the wish for food intake and / or the quantity of the meal consumed. We examined 20 normal-weight males (age 25±1.7 years, BMI 24±0.5 kg/m(2)) in a prospective double-blind randomized fashion. On two different days they obtained a ghrelin infusion 1 ng/kg/min or intravenous saline starting one hour after a standardized meal. Hunger and satiety ratings were documented by visual analogue scales. A second meal was served on demand and consumed until feeling satiated. Time point of the second meal as well as ingested calories were registered. Prior to the start of i.v. ghrelin the postprandial decrease of active plasma ghrelin by 30 pg/ml was comparable. In the controls the postprandial reduction was significant until 210 min compared to basal. With i.v. ghrelin basal levels were reached within 10 min. The maximal rise was twice basal. No effect was observed on hunger and satiety ratings. The time period between the meals and the food quantity of the second meal were similar. During ghrelin infusion glucose and growth hormone but not insulin and cortisol levels were significantly higher after the second meal compared to saline. The present data demonstrate for the first time the effect of a low dose ghrelin infusion on food intake. Neither physiological nor moderably supraphysiological ghrelin levels were associated with any change of the various food intake parameters determined. These data do not favour a hormonal role of peripheral ghrelin in the regulation of food intake.
authors: Division of Gastroenterology, Medizinische Klinik Campus Innenstadt, Klinikum der LMU, Munich, Germany. florian.lippl@med.uni-muenchen.de
authors: Florian
authors: F
authors: Lippl
authors: Johannes
authors: J
authors: Erdmann
authors: Amelie
authors: A
authors: Steiger
authors: Nicole
authors: N
authors: Lichter
authors: Cäcilia
authors: C
authors: Czogalla-Peter
authors: Martin
authors: M
authors: Bidlingmaier
authors: Sylvia
authors: S
authors: Tholl
authors: Volker
authors: V
authors: Schusdziarra
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004435:Eating / Q000187:drug effects*; D054439:Ghrelin / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology*; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D006815:Hunger / Q000187:drug effects; D006854:Hydrocortisone / Q000097:blood*; D007328:Insulin / Q000097:blood; D008297:Male; D012528:Satiety Response / Q000187:drug effects
chemical_list: D001786:Blood Glucose; D054439:Ghrelin; D007328:Insulin; D013006:Growth Hormone; D006854:Hydrocortisone